FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113886491> ?p ?o ?g. }

• W2113886491 endingPage "1708" @default.
• W2113886491 startingPage "1699" @default.
• W2113886491 abstract "The influence of p53 function and caspase 3 activity on the capacity of the antifolate, methotrexate, to promote senescence arrest and apoptotic cell death was investigated in breast tumor cells. In p53 wild-type, but caspase 3 deficient MCF-7 breast tumor cells, death of approximately 40% of the cell population was observed immediately after acute exposure to 10 microM methotrexate (the IC80 value for a 2 h drug exposure). There was no evidence of either DNA fragmentation, a sub G0 population or morphological alterations indicative of apoptosis; however, PARP cleavage was detected. Cell death was succeeded by growth arrest for at least 72 h--where arrest was characterized by expression of the senescence marker, beta-galactosidase. The response to methotrexate in MCF-7/E6 cells with attenuated p53 function was also primarily growth arrest--but lacking characteristics of senescence. In contrast, MCF-7 cells which expressed caspase 3 demonstrated a gradual and continuous loss of cell viability and unequivocal morphological evidence of apoptosis. DNA fragmentation indicative of apoptosis was also detected after exposure to methotrexate in p53 mutant MDA-MB231 breast tumor cells which also express caspase 3. Methotrexate-induced both p53 and p21waf1/cip1 in MCF-7 cells within 6 h; however, no significant DNA strand breakage was evident before 18 h, suggesting that the induction of p53 reflects a response to cellular stress other than DNA damage, such as nucleotide depletion. Overall, these studies suggest that the nature of the cellular response to methotrexate depends, in large part, on p53 and caspase function. p53 appears to be required for methotrexate-induced senescence, but not apoptosis, caspase 3 is required for DNA fragmentation and the morphological changes associated with apoptosis, while neither p53 nor caspase 3 are required for methotrexate-induced growth arrest. Furthermore, the senescence phenotype may occur in the absence of direct DNA damage." @default.
• W2113886491 created "2016-06-24" @default.
• W2113886491 creator A5004156347 @default.
• W2113886491 creator A5018946268 @default.
• W2113886491 creator A5019367459 @default.
• W2113886491 creator A5041168206 @default.
• W2113886491 creator A5063037013 @default.
• W2113886491 creator A5067950960 @default.
• W2113886491 creator A5078463388 @default.
• W2113886491 date "2004-11-01" @default.
• W2113886491 modified "2023-10-12" @default.
• W2113886491 title "Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell" @default.
• W2113886491 cites W1507212424 @default.
• W2113886491 cites W1541964738 @default.
• W2113886491 cites W1594621311 @default.
• W2113886491 cites W1775749144 @default.
• W2113886491 cites W1965024555 @default.
• W2113886491 cites W1977652201 @default.
• W2113886491 cites W1978689713 @default.
• W2113886491 cites W1979319210 @default.
• W2113886491 cites W1988007280 @default.
• W2113886491 cites W1989864703 @default.
• W2113886491 cites W1990475086 @default.
• W2113886491 cites W1991494214 @default.
• W2113886491 cites W1999014427 @default.
• W2113886491 cites W2007091552 @default.
• W2113886491 cites W2017456445 @default.
• W2113886491 cites W2021491682 @default.
• W2113886491 cites W2025404530 @default.
• W2113886491 cites W2026885876 @default.
• W2113886491 cites W2027344216 @default.
• W2113886491 cites W2035845813 @default.
• W2113886491 cites W2045563337 @default.
• W2113886491 cites W2047861739 @default.
• W2113886491 cites W2058350919 @default.
• W2113886491 cites W2067138103 @default.
• W2113886491 cites W2072363468 @default.
• W2113886491 cites W2077273625 @default.
• W2113886491 cites W2084470802 @default.
• W2113886491 cites W208756186 @default.
• W2113886491 cites W2104908670 @default.
• W2113886491 cites W2111175813 @default.
• W2113886491 cites W2112312770 @default.
• W2113886491 cites W2115535498 @default.
• W2113886491 cites W2130787281 @default.
• W2113886491 cites W2135196225 @default.
• W2113886491 cites W2138302361 @default.
• W2113886491 cites W2141042028 @default.
• W2113886491 cites W2142596140 @default.
• W2113886491 cites W2155310577 @default.
• W2113886491 cites W2156114133 @default.
• W2113886491 cites W2161453810 @default.
• W2113886491 cites W2166029855 @default.
• W2113886491 cites W2166152547 @default.
• W2113886491 cites W2315283231 @default.
• W2113886491 cites W2321119724 @default.
• W2113886491 cites W2326870974 @default.
• W2113886491 cites W2327859388 @default.
• W2113886491 cites W41119153 @default.
• W2113886491 doi "https://doi.org/10.1016/j.bcp.2004.06.033" @default.
• W2113886491 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15450935" @default.
• W2113886491 hasPublicationYear "2004" @default.
• W2113886491 type Work @default.
• W2113886491 sameAs 2113886491 @default.
• W2113886491 citedByCount "46" @default.
• W2113886491 countsByYear W21138864912012 @default.
• W2113886491 countsByYear W21138864912013 @default.
• W2113886491 countsByYear W21138864912014 @default.
• W2113886491 countsByYear W21138864912015 @default.
• W2113886491 countsByYear W21138864912016 @default.
• W2113886491 countsByYear W21138864912017 @default.
• W2113886491 countsByYear W21138864912018 @default.
• W2113886491 countsByYear W21138864912019 @default.
• W2113886491 countsByYear W21138864912020 @default.
• W2113886491 countsByYear W21138864912021 @default.
• W2113886491 countsByYear W21138864912022 @default.
• W2113886491 countsByYear W21138864912023 @default.
• W2113886491 crossrefType "journal-article" @default.
• W2113886491 hasAuthorship W2113886491A5004156347 @default.
• W2113886491 hasAuthorship W2113886491A5018946268 @default.
• W2113886491 hasAuthorship W2113886491A5019367459 @default.
• W2113886491 hasAuthorship W2113886491A5041168206 @default.
• W2113886491 hasAuthorship W2113886491A5063037013 @default.
• W2113886491 hasAuthorship W2113886491A5067950960 @default.
• W2113886491 hasAuthorship W2113886491A5078463388 @default.
• W2113886491 hasConcept C105696609 @default.
• W2113886491 hasConcept C143425029 @default.
• W2113886491 hasConcept C153911025 @default.
• W2113886491 hasConcept C18903297 @default.
• W2113886491 hasConcept C190283241 @default.
• W2113886491 hasConcept C191015642 @default.
• W2113886491 hasConcept C2908647359 @default.
• W2113886491 hasConcept C29537977 @default.
• W2113886491 hasConcept C31573885 @default.
• W2113886491 hasConcept C43759708 @default.
• W2113886491 hasConcept C502942594 @default.
• W2113886491 hasConcept C522857546 @default.
• W2113886491 hasConcept C552990157 @default.

• next